(2052–2107) SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes

Monday, November 14, 2022

1:00 PM – 3:00 PM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

1:00 PM – 3:00 PM Eastern Time

Vaccine Uptake in Women with Systemic Lupus Erythematosus (SLE) in a Large Urban Teaching Hospital Serving a High-Risk Population
Abstract Poster Presenter: J. Patricia Dhar, MD – Ascension St. John Hospital and Wayne State Univeristy School of Medicine
1:00 PM – 3:00 PM Eastern Time

Current State and Completeness of Reporting Clinical Prediction Models Using Machine Learning in Systemic Lupus Erythematosus: A Systematic Review
Abstract Poster Presenter: Claudia Mendoza-Pinto, MD, PhD – Instituto Mexicano del Seguro Social
1:00 PM – 3:00 PM Eastern Time

Towards a Novel Clinician-Reported Outcome Measure for SLE - Outcomes of an International Consensus Process
Abstract Poster Presenter: Kathryn Connelly, MBBS – Monash Health
1:00 PM – 3:00 PM Eastern Time

SRI-4 and BICLA: How Well Do They Agree Across Trials of Active Systemic Lupus Erythematosus?
Abstract Poster Presenter: Alfredo Aguirre, MD – University of California, San Francisco
1:00 PM – 3:00 PM Eastern Time

Long Term Safety and Effectiveness of Belimumab Therapy in Patient with SLE: A Single Center Retrospective Analysis
Abstract Poster Presenter: Takehiro Nakai, MD – St. Luke's International Hospital
1:00 PM – 3:00 PM Eastern Time

Outpatient Visit Adherence and Impact on Disease-related Morbidity in Childhood-onset Systemic Lupus Erythematosus (cSLE)
Abstract Poster Presenter: Meghan Nelson, DO – Emory
1:00 PM – 3:00 PM Eastern Time

Evidence on the Construct Validity of the Perceived Deficits Questionnaire Among Adult Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Stefan Perera, MD, MSc – University of Toronto
1:00 PM – 3:00 PM Eastern Time

Association of Hydroxychloroquine with the Incidence of Infectious Disease in Systemic Lupus Erythematosus: Data from the LUNA Registry
Abstract Poster Presenter: Chiharu Hidekawa, MD – Yokohama City University
1:00 PM – 3:00 PM Eastern Time

Increased Risk of Adverse Renal Outcomes in Patients of African Ancestry with Systemic Lupus Erythematosus (SLE) – Role of APOL1
Abstract Poster Presenter: Vivian Kawai, MD – Vanderbilt University Medical Center
1:00 PM – 3:00 PM Eastern Time

Impact of Time to Remission, Flares and Exposure to Immunosuppressives on the Development of Advanced Chronic Kidney Disease (Stage IV or Worse) in Lupus Nephritis
Abstract Poster Presenter: KONSTANTINOS TSELIOS, MD, PhD – McMaster University
1:00 PM – 3:00 PM Eastern Time

Predicting Severe Flares: Real-world Application of a Decision-Tree Model Among the Medicaid-Insured Systemic Lupus Erythematosus (SLE) Population in the US
Abstract Poster Presenter: Sandra Wu, PhD – AstraZeneca
1:00 PM – 3:00 PM Eastern Time

Medication Cost Concerns and Disparities in Patient-reported Outcomes Among a Multiethnic Cohort of Patients with Lupus
Abstract Poster Presenter: Alfredo Aguirre, MD – University of California, San Francisco
1:00 PM – 3:00 PM Eastern Time

Trajectories of Disease Activity in a Longitudinal Registry of Pediatric SLE
Abstract Poster Presenter: Siobhan Case, MD, BA, MHS – Brigham and Women's Hospital, Boston Children's Hospital
1:00 PM – 3:00 PM Eastern Time

Sustained B Cell Depletion in Lupus Nephritis Patients After Treatment with a B Cell Agent Is Associated with Fewer Disease Flares
Abstract Poster Presenter: Diane Zisa, MD – Columbia University Irving Medical Center
1:00 PM – 3:00 PM Eastern Time

Measuring Sexual Dysfunction as an Indicator of Frailty in Systemic Lupus Erythematosus Population
Abstract Poster Presenter: Daniela Marengo-Rodriguez, MD – Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
1:00 PM – 3:00 PM Eastern Time

Predictors of Organ Damage Accrual by Domains
Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
1:00 PM – 3:00 PM Eastern Time

All-Cause Mortality in a Systemic Lupus Erythematosus Cohort
Abstract Poster Presenter: Michelle Petri, MD, MPH – Johns Hopkins University School of Medicine
1:00 PM – 3:00 PM Eastern Time

Responsiveness of the Patient Reported Outcomes Measurement Information System (PROMIS) Computerized Adaptive Test (CAT) Measures in a Single Canadian Lupus Cohort
Abstract Poster Presenter: Aarabi Thayaparan, BSc – Schroeder Arthritis Institute, Krembil Research Institute
1:00 PM – 3:00 PM Eastern Time

Health-Related Quality of Life Across the Spectrum of Connective Tissue Diseases: A Latent Profile Analysis
Abstract Poster Presenter: Sarah Dyball, MBBS, BSc – University of Manchester
1:00 PM – 3:00 PM Eastern Time

The Systemic Lupus Erythematosus International Collaborating Clinics (SLICC), American College of Rheumatology (ACR), and Lupus Foundation of America (LFA) Damage Index Revision - Item Generation Phase
Abstract Poster Presenter: Burak Kundakci, PhD, MSc – University of Manchester
1:00 PM – 3:00 PM Eastern Time

Estimating Corticosteroid-Related Morbidity in Lupus Nephritis: The Glucocorticoid Toxicity Index
Abstract Poster Presenter: Ilana Usiskin, MD – Beth Israel Deaconess Medical Center
1:00 PM – 3:00 PM Eastern Time

The Incidence of COVID-19 Infection in an SLE Cohort, and Its Association with Immunosuppressants, SLE Disease Activity, Vaccination Status, and COVID-19 Antibodies
Abstract Poster Presenter: Laurence Magder, PhD – University of Maryland, Baltimore
1:00 PM – 3:00 PM Eastern Time

Poor Executive Function Correlates with Increased Disease Damage and Impaired Patient-Reported Outcomes in Youth with Childhood-Onset Lupus: A Cross-Sectional Study
Abstract Poster Presenter: Tala El Tal, MD – University of Toronto/Hospital for Sick Children
1:00 PM – 3:00 PM Eastern Time

Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Moderate to High Dose Glucocorticoids
Abstract Poster Presenter: Mi Hyeon Kim, MD – Seoul National University Hospital
1:00 PM – 3:00 PM Eastern Time

Unfavorable Outcomes Associated with Current Standard of Care in the Management of Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Zahi Touma, MD, PhD – University of Toronto
1:00 PM – 3:00 PM Eastern Time

Does Early Complete Remission Preclude Adverse Outcomes in Lupus Nephritis?
Abstract Poster Presenter: KONSTANTINOS TSELIOS, MD, PhD – McMaster University
1:00 PM – 3:00 PM Eastern Time

Mesangial Lupus Nephritis: Long Term Outcomes
Abstract Poster Presenter: KONSTANTINOS TSELIOS, MD, PhD – McMaster University
1:00 PM – 3:00 PM Eastern Time

Survey to Prioritize and Generate Domains in Preparation to Update the OMERACT Core Domain Set for Systemic Lupus Erythematosus
Abstract Poster Presenter: Wils Nielsen, MSc – University of Toronto
1:00 PM – 3:00 PM Eastern Time

Epidemiology and Outcomes of Emergency Department Visits in Systemic Lupus Erythematosus: Data from National Emergency Database Sample
Abstract Poster Presenter: Rashmi Dhital, MD – UC San Diego
1:00 PM – 3:00 PM Eastern Time

COVID-19 Infections, Morbidity, and Seroreactivity in SLE Patients Following Initial Vaccination Series and Additional Dose Through the New York City Omicron BA.1 Wave
Abstract Poster Presenter: Amit Saxena, MD – NYU School of Medicine
1:00 PM – 3:00 PM Eastern Time

A Prospective Study on Long-Term Clinical Outcomes of Patients with Lupus Nephritis Treated with an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
Abstract Poster Presenter: DARIO ROCCATELLO, MD – UNIVERSITA' DEGLI STUDI DI TORINO
1:00 PM – 3:00 PM Eastern Time

A Network Meta-analysis on 532 SLE Patients: Low Complement Levels in the First Trimester Predict Disease Flare in Pregnancy
Abstract Poster Presenter: Savino Sciascia, MD – University of Turin
1:00 PM – 3:00 PM Eastern Time

COVID-19 Vaccination in Autoimmune Diseases Study: Vaccine Safety in Systemic Lupus Erythematosus
Abstract Poster Presenter: Naveen R, DM – Sanjay Gandhi Post graduate institute of medical sciences
1:00 PM – 3:00 PM Eastern Time

Effect of Osteoporosis on Major Adverse Cardiovascular Events (MACEs) and Mortality in Systemic Lupus Erythematosus: A Longitudinal Study
Abstract Poster Presenter: Chi Chiu Mok, MD;FRCP – Tuen Mun Hospital
1:00 PM – 3:00 PM Eastern Time

Remission and Low Disease Activity Are Associated with Lower Health Care Costs in an International Inception Cohort of Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Ann Clarke, MD, MSc – University of Calgary
1:00 PM – 3:00 PM Eastern Time

Prospective Study of Clinical, Laboratory, and Patient-Reported Outcomes of Patients with Systemic Lupus Erythematosus Undergoing Total Hip and Total Knee Arthroplasty
Abstract Poster Presenter: David Fernandez, MD, PhD – Hospital for Special Surgery
1:00 PM – 3:00 PM Eastern Time

Achieving Systemic Lupus Erythematosus Disease Control or Low Lupus Disease Activity State Is Associated with Lower Rates of Organ Damage: Results from the Hopkins Lupus Cohort
Abstract Poster Presenter: Jake Hunnicutt, PhD – GSK, Value Evidence and Outcomes
1:00 PM – 3:00 PM Eastern Time

The Implication of Skin Involvement on Health-Related Quality of Life (HRQoL) in Systemic Lupus Erythematosus (SLE) Patients
Abstract Poster Presenter: Alicia Van, BSc – Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto
1:00 PM – 3:00 PM Eastern Time

Evaluation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) vs. SLEDAI-2K Glucocorticoids (SLEDAI-2KG) on Patient Health-Related Quality of Life (HRQoL) in Systemic Lupus Erythematosus (SLE)
Abstract Poster Presenter: Alan Cheng, BSc – McMaster University
1:00 PM – 3:00 PM Eastern Time

Burden and Incidence of Multimorbidity in Systemic Lupus Erythematosus in a Community Population-Based Cohort: The Lupus Midwest Network
Abstract Poster Presenter: Gabriel Figueroa-Parra, MD – Mayo Clinic
1:00 PM – 3:00 PM Eastern Time

Greater Social Vulnerability Associates with Greater Glucocorticoid Use in Patients with SLE
Abstract Poster Presenter: Avira Som, MD – Washington University School of Medicine in St. Louis
1:00 PM – 3:00 PM Eastern Time

Hazard Index Equations Using Data Collected at Baseline and After One Year Treatment Allow Early Prediction of Poor Outcome in an Incident Lupus Nephritis Population: Data from the Louvain Lupus Nephritis Cohort
Abstract Poster Presenter: Farah Tamirou, MD – Cliniques universitaires Saint-Luc
1:00 PM – 3:00 PM Eastern Time

Predictors of Health-Related Quality of Life (HRQoL) in Adults with Juvenile- and Adult-onset Systemic Lupus Erythematosus: Results from a Multiethnic US Cohort (LUMINA)
Abstract Poster Presenter: R. Ezequiel Borgia, MD, MS – University Hospitals Rainbow Babies & Children's Hospital
1:00 PM – 3:00 PM Eastern Time

Validation Analysis of the Physician Global Assessment (PGA) Scale in Patients with Systemic Lupus Erythematosus Included in RELESSER-PROS Registry
Abstract Poster Presenter: Jaime Calvo Alén, MD, PhD – Hospital Universitario Araba
1:00 PM – 3:00 PM Eastern Time

Role of Cell-Bound Complement Fragments as Biomarkers to Determine Disease Activity in Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Marcela Muñoz Urbano, MD – Universidad de Antioquia
1:00 PM – 3:00 PM Eastern Time

Association of Renal Biopsy NIH Activity and Chronicity Scores with Clinical Outcomes in a Cohort of Patients with Lupus Nephritis
Abstract Poster Presenter: David Kellner, MD – UCLA
1:00 PM – 3:00 PM Eastern Time

Analysis of Cutaneous Lupus Hospitalizations: A United States National Population-based Study
Abstract Poster Presenter: Amy Trang, MD – Rush University Medical Center
1:00 PM – 3:00 PM Eastern Time

Drug Repurposing for Treating Lupus Nephritis Based on Transcriptome Profiling and Autoimmunity-Related Serological Markers
Abstract Poster Presenter: Ioannis Parodis, MD, PhD – Karolinska Institutet
1:00 PM – 3:00 PM Eastern Time

Employment Trajectory of Canadian Young Adults with Systemic Lupus Erythematosus
Abstract Poster Presenter: Lily Lim, MD, PhD – University of Manitoba
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

Does Remission According Definition of Remission in SLE (DORIS) 2021 Match the Treating Rheumatologist Judgment? Analysis at Recruitment of a Prospective Study of 500 SLE Patients from a Spanish Multicenter Cohort
Abstract Poster Presenter: Irene Altabas Gonzalez, MD – Complejo Hospitalario de Vigo
1:00 PM – 3:00 PM Eastern Time

Association of Telomere Length with Phenotypic Frailty in Adults with Systemic Lupus Erythematosus
Abstract Poster Presenter: Sarah Lieber, MD, MS – Hospital for Special Surgery
1:00 PM – 3:00 PM Eastern Time

The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE
Abstract Poster Presenter: Jennifer Rogers, MD – Duke
1:00 PM – 3:00 PM Eastern Time

Comparison of the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) and the FRAIL Scale for Identifying Frailty Among Individuals with Systemic Lupus Erythematosus
Abstract Poster Presenter: Alexandra Legge, MD, FRCPC, MSc – Dalhousie University
1:00 PM – 3:00 PM Eastern Time

Disparities of African American Mortality Trends in South Carolina Lupus Cohort
Abstract Poster Presenter: Sean Carter, MD, BS – MUSC
1:00 PM – 3:00 PM Eastern Time

Pregnancy Outcomes Among Women with Systemic Lupus Erythematosus (SLE): Impact of Preexisting Hypertension
Abstract Poster Presenter: Azalfa Lateef, BS – MUSC